| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia |
| 02/22/2007 | US20070041996 Aromatase activating agent |
| 02/22/2007 | US20070041976 Treating septic arthritis; Interleukin-4 (IL-4), previously known as B cell stimulating factor |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2619720A1 Process for the preparation of strontium ranelate |
| 02/22/2007 | CA2619545A1 Novel use of peptide compounds for treating muscle pain |
| 02/22/2007 | CA2618614A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754476A1 Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| 02/21/2007 | EP1753764A1 Pyrrolopyridine derivatives |
| 02/21/2007 | EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2007 | EP1569924A4 Nf-kb inhibitors |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1356811B1 Combination of three substances for the prevention or treatment of arthritis |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 02/21/2007 | CN1918139A Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them |
| 02/21/2007 | CN1918134A Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918127A New cyclocompound having 4-pyridylalkylthio group to which sustituted or unsubstituted amino group is introduced |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917890A Composition and method for use in cartilage affecting conditions |
| 02/21/2007 | CN1917889A Use of gallium to treat inflammatory arthritis |
| 02/21/2007 | CN1917873A Diurea derivatives |
| 02/21/2007 | CN1917869A Composition and method for use in cartilage affecting conditions |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/21/2007 | CN1915407A Medicated wine |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1915343A Prepared Chinese medicine for treating slow healing of fracture |
| 02/21/2007 | CN1915326A Composition for treating gout |
| 02/21/2007 | CN1915315A Enteric-coated prepartioon of compound rhizome of Sichuan lovage (notoperygium root) and Indomethacin, and preparation |
| 02/21/2007 | CN1915310A Medication for treating disease of proplapse of lumbar intervertebral disc |
| 02/21/2007 | CN1915236A Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis |
| 02/21/2007 | CN1915235A Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1301261C Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid and preparation method thereof |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301129C Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones |
| 02/21/2007 | CN1301122C Bone strengthening granule of tortoise plastron and astragalus root |
| 02/21/2007 | CN1301118C Chinese medicine formulation for treating calcaneus spur |
| 02/21/2007 | CN1301115C Medicine for hyperosteogeny and its preparation |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179649 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2198389C Triphenylethylenes for the prevention and treatment of osteoporosis |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007017643A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 02/15/2007 | WO2006062424A3 Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
| 02/15/2007 | CA2620952A1 3, 11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2618069A1 Dihydroxyanthraquinones and their use |
| 02/15/2007 | CA2616437A1 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
| 02/14/2007 | EP1752446A2 Compounds for modulating cell proliferation |
| 02/14/2007 | EP1752163A1 Agent for actively restoring structure and functions of damaged tissues and organs |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751175A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 02/14/2007 | EP1751172A1 Novel 3-triazolyl-galactoside inhibitors of galectins |
| 02/14/2007 | EP1751171A1 Novel galactoside inhibitors of galectins |
| 02/14/2007 | EP1751167A1 Thienopyridine derivatives, production method and use thereof |
| 02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 02/14/2007 | EP1750756A2 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 02/14/2007 | EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases |
| 02/14/2007 | EP1750692A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 02/14/2007 | EP1750669A1 Solid pharmaceutical form comprising an ltb4 antagonist |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |